Montmorency tart cherry shows gout potential: Study

By Lynda Searby

- Last updated on GMT

Dr Glyn Howatson: "Here, inflammation was reduced following both doses of the concentrate.”
Dr Glyn Howatson: "Here, inflammation was reduced following both doses of the concentrate.”
Evidence that Montmorency tart cherry could be useful in managing gouty arthritis and other inflammatory conditions is mounting, as a new study shows that tart cherry concentrate lowers uric acid and C-reactive protein – a marker for inflammation.

In the study, published in the Journal of Functional Foods​, supplementation with Montmorency tart cherry concentrate at dose levels of 30 and 60 ml decreased blood levels of uric acid whilst increasing urinary uric acid.

“Put simply, uric acid crystallises in the toes – usually the great toe – and causes excruciating pain – If you can lower uric acid, you might also reduce issues associated with gout,” ​explained lead researcher Dr Glyn Howatson, from the Department of Sport, Exercise and Rehabilitation at Northumbria University.

Blood levels of hsCRP (high sensitivity C-reactive protein) – a marker for inflammation – were also decreased.

“Systemic inflammation, as indicated by hsCRP, is a clinically accepted marker of whole body inflammation...Here, inflammation was reduced following both doses of the concentrate,”​ wrote the researchers.

Effect on a par with drugs

They said this corroborated previous work that demonstrated the anti-inflammatory effect of isolated tart cherry anthocyanins as being comparable to commercially available non-steroidal anti-inflammatory drugs (NSAIDs).

“The impact of Montmorency cherry concentrate on inflammation may provide further efficacy for its use in the treatment of inflammatory disorders,”​ they said.

The study used a tart cherry concentrate from Cherry Active and was sponsored by the Cherry Marketing Institute.

In terms of the next step, Dr Howatson told this publication: “We would particularly like to explore this intervention in a clinical population who have gouty arthritis, but we are also interested in what other physiological effects it may exert.”

Study design

In the current single blind, two-phase, randomised, cross-over study, 12 healthy participants (average age 26) were given two doses of Montmorency tart cherry juice concentrate (30 ml or 60 ml) mixed with 100 ml of water.

There was a washout period of at least 10 days between the phases. Each phase was comprised of two days drinking the tart cherry juice concentrate twice a day – in the morning and just before dinner.

The researchers collected blood and urine samples from the participants immediately before and at numerous intervals for 48 hours after the tart cherry juice was consumed.

The results supported the researchers' hypothesis: Blood levels of uric acid and C-reactive protein were reduced and urinary uric acid was increased following both doses of the tart cherry juice. The magnitude of the change was independent of the dose given; that is, 30 ml of the juice was just as effective as 60 ml.

“Consequently, a 30 ml dose of cherry concentrate was sufficient to modulate indices associated with gout outbreaks,”​ wrote the researchers.

Anthocyanins responsible?

gout
“These are the first data to show Montmorency cherry concentrate as an efficacious, adjuvant supplement in managing inflammatory conditions, such as those seen with gout..."

This work was the first to report the plasma uptake of anthocynanin compounds following Montmorency cherry consumption, which has previously been suggested to be responsible for changes in uric acid metabolism.

The main anthocyanin identified in the tart cherry concentrate was CYA-3-O-glucosiderutinoside. Plasma CYA-3-O-GluRut levels were found to be no different between doses, although the 60 ml dose showed a greater level of absorption in the first hour following supplementation.

The researchers said this suggests that, “despite plasma availability of CYA-3-O-GluRut being higher with a larger dose, the uric acid activity was not affected”​.

They said that whilst their work did not refute the suggestion that anthocyanins are responsible for reductions in uric acid, “it seems that there is a finite amount of anthocyanin compounds required to elicit a change”.

In summary the researchers said the results provide rationale for the use of Montmorency cherry concentrate as an adjuvant therapy to NSAIDs in the treatment of gouty arthritis.

“These are the first data to show Montmorency cherry concentrate as an efficacious, adjuvant supplement in managing inflammatory conditions, such as those seen with gout, and those observations are independent of CYA-3-O-GluRut absorption in humans,”​ they concluded.

 

Source: Journal of Functional Foods

2014; 11 : 82-90.

“Montmorency tart cherry (Prunus cerasus L.) concentrate lowers uric acid, independent of plasma cyanidin-3-O-glucosiderutinoside”

Authors: Bell PG, Gaze DC, Davison GW, George TW, Scotter MJ, Howatson G. 

Related news

Show more

Related products

show more

GlycOmega™-PLUS: Beyond Greenshell™ mussel powder

GlycOmega™-PLUS: Beyond Greenshell™ mussel powder

LEHVOSS Nutrition– Gee Lawson | 04-Feb-2019 | Technical / White Paper

From Aroma NZ Ltd, GlycOmega™ PLUS is the new generation of Greenshell™ mussel meat extract, which LEHVOSS Nutrition is pleased to add to the Gee Lawson...

The Ingredients Show 2019 NEC Birmingham

The Ingredients Show 2019 NEC Birmingham

William Reed | 01-Jan-2019 | Product Brochure

We’ve been bringing food and drink markets together for over 150 years. And the drive to
inform and serve our sectors that fuelled the launch of...

Indena’s approach in supporting sport nutrition

Indena’s approach in supporting sport nutrition

Indena: the botanical ingredient of Health Food industry | 22-Nov-2018 | Technical / White Paper

Edible plants confirm to be a paramount source of precious substances able to help in maintaining the overall wellbeing and complement the nutrition of...

Related suppliers

2 comments

potassium bicarbonte to cure gout

Posted by Charles Weber,

Potassium deficiency is deeply involved in gout and high uric acid as an accentuating factor because uric acid is less soluble in acidic urine. Potassium bicarbonate supplements will reverse this. In view of the fact that this is not considered by current rheumatologists, it would be very valuable for you to bring it into your future writing. It is not only that potassium is not considered by physicians in regard to gout, many of them do not even believe that a potassium deficiency is likely. This even though many of them prescribe what are actually supplements, but prescribed under euphemistic terms such as salt substitutes, sodium free baking powder, ORT salts (oral rehydration therapy for diarrhea), polarizing solutions, GIK (glucose, insulin, potassium) salts, vegetables, or glucosamine. A deficiency is further defined out of existence by defining the blood serum content normal as 4.2 when the actual figure is 4.8. For gout, though, the chloride is not acceptable. But potassium bicarbonate powder dissolved in fruit juice or half teaspoon sprinkled on cereal will work very well. It may be obtained from businesses which add it to wine. You may see an article on this concept in http://www.webmedcentral.com/article_view/4217 . If you supplement potassium, be very certain that vitamin B-1 is adequate, because otherwise heart disease can be triggered (see http://charles_w.tripod.com/kandthiamin.html ).
Sincerely, Charles Weber

Report abuse

Gout Pain

Posted by Charles Privara,

Where do you get this product or how can you be in a study? I get gout and it is one of the most painful ailments you can get.

Report abuse

Follow us

Featured Events

View more

Products

View more

Webinars